I just returned from a workshop sponsored by the FDA (and the NHLBI and NSF) on Computer Methods for Cardiovascular Devices. It was an excellent workshop providing an audience of regulatory, academic and industrial interests a chance to get caught up on the state-of-the-art, trends and, in general, to exchange ideas on the issues of [...]